a cyclical issue with a great story backed up by solid funding
and experts across sectors
it is a survivor
and it rewards early speculators
even strong hands who can average down before the facts news and disclosures
whatever the TREND is
this stock is a facility for heavy hitters to bankroll
and make a windfall for those who got VOLUME at cost of HANDLER
Strategy: the usual Cost Average
Tactic: Buy High Price go Up
dna: DiGiPLUS ACEN DiTO
and experts across sectors
it is a survivor
and it rewards early speculators
even strong hands who can average down before the facts news and disclosures
whatever the TREND is
this stock is a facility for heavy hitters to bankroll
and make a windfall for those who got VOLUME at cost of HANDLER
Strategy: the usual Cost Average
Tactic: Buy High Price go Up
dna: DiGiPLUS ACEN DiTO
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。